Precision-Enhancing Risk Stratification Tools for Selecting Optimal Treatment Durations in Tuberculosis Clinical Trials

Rationale: No evidence-based tools exist to enhance precision in the selection of patient-specific optimal treatment durations to study in tuberculosis clinical trials. Objectives: To develop risk stratification tools that assign patients with tuberculosis into risk groups of unfavorable outcome and...

Descripción completa

Detalles Bibliográficos
Autores principales: Imperial, Marjorie Z., Phillips, Patrick P. J., Nahid, Payam, Savic, Radojka M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663006/
https://www.ncbi.nlm.nih.gov/pubmed/34346856
http://dx.doi.org/10.1164/rccm.202101-0117OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663006/
https://www.ncbi.nlm.nih.gov/pubmed/34346856
http://dx.doi.org/10.1164/rccm.202101-0117OC

Ejemplares similares